Two Sigma Securities’s Apollo Endosurgery, Inc. APEN Stock Holding History

Two Sigma Securities’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-13,975	Closed	-$113K	–	2067
2021 Q2	$113K	Buy	+13,975	New	+$95.9K	﹤0.01%	1350
2016 Q2	–	Sell	-297	Closed	-$4K	–	549
2016 Q1	$4K	Buy	+297	New	+$4.13K	0.01%	283

Other funds holding APEN

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

PGM

Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Securities's APEN Position: Q3 2021 in Review

Two Sigma Securities sold out of Apollo Endosurgery, Inc. (APEN) in Q3 2021, closing a stake of 13,975 shares — an estimated $113K sold.

Two Sigma Securities first reported a position in APEN in Q1 2016 and held it in 2 quarters. The position peaked at $113K in Q2 2021. 55 funds tracked by Wall St. Rank hold APEN as of Q3 2021.

Two Sigma Securities reported no remaining Apollo Endosurgery, Inc. position as of Q3 2021 after selling out during the quarter.
Two Sigma Securities sold 13,975 Apollo Endosurgery, Inc. shares in Q3 2021, an estimated $113K.
Two Sigma Securities first reported a position in Apollo Endosurgery, Inc. in Q1 2016 and held it in 2 quarters.
Two Sigma Securities's Apollo Endosurgery, Inc. position peaked at $113K in Q2 2021.
55 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q3 2021.

Based on Two Sigma Securities's 13F filing for Q3 2021, filed 15 Nov 2021.